With a malignant brain tumor - glioblastoma, there is no effective treatment.

Surgical removal of the tumor, and then intensive chemotherapy and radiation therapy prolong the life of patients for only a few months.

Death follows the patients no later than one year after the first operation.

Located in the soft tissues of the brain, glioma deeply directs its tentacles and, after removal with a scalpel or laser, instantly grows again.

New hopes for the treatment of cancer of this oncology are associated with the discovery that American scientists working for the Transmolecular Corporation in Cambridge, Massachusetts,.

They found that the poison of the Israeli yellow scorpion has a structure similar in structure to glioblastoma cells and decided to try using it for treatment. The new method consists not in the simple action of homeopathic medicine, where a small number of specially selected poisons makes it possible to eliminate the disease caused by such toxins.

Here scientists created a synthetic version of the scorpion's poison and added to it the radioactive isotope of i-131 iodine, the one that after the Chernobyl accident infected half of Europe. Due to the specific properties of scorpion venom, a new drug, made in the form of injections, is fed directly into the brain, acting solely on glioma cells.

And since the products are built radioactive iodine, cancer cells begin to under its influence to die. Thus, the scorpion poison is only a vehicle of radioactive substances. The drug was called TN-601 and is currently in clinical trials.

To protect the thyroid gland from the harmful effects of the drug, the patient before receiving therapy receives a large dose of liquid iodine.

The selected dose of a radioactive element (according to oncologists) is as safe for the environment as it is for the treatment of thyroid cancer. Patients who receive an injection of TN-601 return home, because there is no need for hospitalization.

Already today it is known that a new medicine has a positive effect on increasing the survival rate of patients. Now scientists are starting the second phase of the experiment and want to increase the i-131 iodine doses.

medbe. en.

Keywords:.